# A Prospective Cluster-Randomized, Controlled Crossover Trial to Validate an Electronic "Resistance Calculator"

> **NCT05304221** · — · RECRUITING · sponsor: **Dror MarChaim, MD** · enrollment: 1500 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **OTHER:** Shamir Resistance Calculator

## Key facts

- **NCT ID:** NCT05304221
- **Lead sponsor:** Dror MarChaim, MD
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-03
- **Primary completion:** 2024-10
- **Final completion:** 2025-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2024-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05304221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05304221, "A Prospective Cluster-Randomized, Controlled Crossover Trial to Validate an Electronic "Resistance Calculator"". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05304221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*